drugset / Trial / NCT06647810

A Study in Healthy People to Test How 2 Different Formulations of BI 690517 Are Taken up in the Body and How Probenecid Influences the Amount of BI 690517 in the Blood

NCT06647810

Phase 1 Completed 15 enrolled Boehringer Ingelheim
RandomizedCrossoverOpen-labelTreatment

Summary

This trial aims to test how two different formulations of BI 690517 are taken up by the body and how probenecid influences the amount of BI 690517 in the blood.

Timeline

Start
2024-11-13
Primary completion
2024-12-12
Completion
2025-01-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Probenecid Small molecule
Subject Vicadrostat Small molecule

Indications

No indication recorded.